First-in-class drug approvals
RecordSTO-QN0R5EHZ2V-5MCK0PF2WY-NJAQFW
China · 2025
First-in-class drug approvals in China were 11 in 2025 (MOFCOM).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- MOFCOM
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
根据国家药监局数据，2025年76个审批的创新药中，有11个是首创新药，但其中仅有4个是国内本土研发。
Checked: the figure 11is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW
Other formats: MLA, Chicago, BibTeX
- MLA
- Ministry of Commerce of China. "2025年我国批准创新药76个 对外授权超千亿美元." 2025, https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW.
- Chicago
- Ministry of Commerce of China. "2025年我国批准创新药76个 对外授权超千亿美元." 2025. https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW.
- BibTeX
- @misc{mofcom2025firstnjaqfw, author = {{Ministry of Commerce of China}}, title = {2025年我国批准创新药76个 对外授权超千亿美元}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW}, note = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- Ministry of Commerce of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 2025年我国批准创新药76个 对外授权超千亿美元
- Type
- Press release
- Published
- —
- Locator
- 2025年我国批准创新药76个 对外授权超千亿美元
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_QN0R5EHZ2V5MCK0PF2WYNJAQFW